Unlocking the future of ovarian cancer treatment

DRG Disease Landscape & Forecast

Key trends in ovarian cancer treatment:

  • Ovarian cancer treatments sustained strong market growth driven by innovation and expanding treatment options
  • New, premium therapies gaining momentum, supported by broader approvals and extended use across patient populations
  • Shifts in treatment leadership toward newer modalities, with emerging drug classes expected to play a larger commercial role
  • Increased competitive pressure on established therapies, as patent expirations and generics reshape the market landscape
Request more information north_east

Complete the form to learn more about the report

The ovarian cancer – Disease Landscape & Forecast (G7) report delivers comprehensive, data-driven insights across the United States, EU5, and Japan. Backed by expert interviews, cutting-edge epidemiology, and real-time drug pipeline intelligence from Cortellis, this report equips you with the strategic foresight needed to excel in the competitive ovarian cancer space.

Key questions answered:

  • What are the expected sales of key drugs used to treat ovarian cancer in the G7 markets over the next 10 years?
  • What is the current treatment paradigm in ovarian cancer?
  • When are the key novel therapies expected to launch for the ovarian cancer market over the next 10 years?
  • What clinical unmet needs remain unfulfilled and represent the top opportunities for drug developers?
View the sample deckfile_download
10-year market forecast (2024-2034)

Provides annualized drug-level sales and patient share projections

Emerging therapy analysis

Covers emerging ADC drug class adoption, PARP inhibitor treatment positioning, and approval and label expansion impacting the market

The global epidemiology section

Examines incidence, drug-treatable populations, and segmentation by drug classification status, stage, and therapy line

Expert insights

Based on 19 in-depth interviews with thought-leading medical oncologists

See the latest Market Event Summary

Download the report to explore how accelerating late stage pipelines are driving change in the evolving ovarian cancer treatment market.

Download the report file_download

What is Disease Landscape & Forecast?

Disease Landscape & Forecast is a premier market intelligence platform, offering:

  • Comprehensive market data including world-class epidemiology, current and emerging therapy insights, and robust drug forecasts
  • Dynamic updates ensuring continuous enhancements to reflect indication-specific developments throughout the year
  • Real-time pipeline intelligence coming directly from Cortellis, with daily updates and interactive figures for in-depth analysis

Download the reportnorth_east

Already a Disease Landscape & Forecast client?

Log in login

Expert insights on ovarian cancer

Built on expert knowledge and rigorous research

  • 19 expert interviews with oncology leaders across the G7 markets
  • Real-time pipeline intelligence powered by Cortellis
  • Robust epidemiological modeling covering key ovarian cancer subpopulations.
Access the brochurefile_download

Complete the form to learn more about the report